Single dose of a VSV-based vaccine rapidly protects macaques from Marburg virus disease

A Marzi, A Jankeel, AR Menicucci, J Callison… - Frontiers in …, 2021 - frontiersin.org
Marburg virus (MARV) is a member of the filovirus family that causes hemorrhagic disease
with high case fatality rates. MARV is on the priority list of the World Health Organization for …

[HTML][HTML] Therapeutic vaccination strategies against EBOV by rVSV-EBOV-GP: the role of innate immunity

AN Pinski, I Messaoudi - Current opinion in virology, 2021 - Elsevier
Zaire Ebola virus (EBOV) is a member of the Filoviridae family. Infection with EBOV causes
Ebola virus disease (EVD) characterized by excessive inflammation, lymphocyte death …

[PDF][PDF] Identification of early gene expression profiles associated with long-lasting antibody responses to the Ebola vaccine Ad26. ZEBOV/MVA-BN-Filo

F Blengio, H Hocini, L Richert, C Lefebvre, M Durand… - Cell Reports, 2023 - cell.com
Ebola virus disease is a severe hemorrhagic fever with a high fatality rate. We investigate
transcriptome profiles at 3 h, 1 day, and 7 days after vaccination with Ad26. ZEBOV and MVA …

STAGEs: A web-based tool that integrates data visualization and pathway enrichment analysis for gene expression studies

CWT Koh, JSG Ooi, EZ Ong, KR Chan - Scientific Reports, 2023 - nature.com
Gene expression profiling has helped tremendously in the understanding of biological
processes and diseases. However, interpreting processed data to gain insights into …

Immune gene expression analysis indicates the potential of a self-amplifying Covid-19 mRNA vaccine

EZ Ong, JX Yee, JSG Ooi, A Syenina, R De Alwis… - npj Vaccines, 2022 - nature.com
Remarkable potency has been demonstrated for mRNA vaccines in reducing the global
burden of the ongoing COVID-19 pandemic. An alternative form of the mRNA vaccine is the …

A Bivalent Bacterium‐like Particles‐Based Vaccine Induced Potent Immune Responses against the Sudan Virus and Ebola Virus in Mice

S Xu, W Li, C Jiao, Z Cao, F Wu, F Yan… - Transboundary and …, 2023 - Wiley Online Library
Ebola virus disease (EVD) is an acute viral hemorrhagic fever disease causing thousands of
deaths. The large Ebola outbreak in 2014–2016 posed significant threats to global public …

Nonhuman Primates Are Protected against Marburg Virus Disease by Vaccination with a Vesicular Stomatitis Virus Vector-Based Vaccine Prepared under Conditions …

CL Cooper, G Morrow, M Yuan, JW Coleman, F Hou… - Vaccines, 2022 - mdpi.com
Vaccines are needed to disrupt or prevent continued outbreaks of filoviruses in humans
across Western and Central Africa, including outbreaks of Marburg virus (MARV). As part of …

Refined innate plasma signature after rVSVΔG-ZEBOV-GP immunization is shared among adult cohorts in Europe and North America

PA Martinez-Murillo, A Huttner, S Lemeille… - Frontiers in …, 2024 - frontiersin.org
Background During the last decade Ebola virus has caused several outbreaks in Africa. The
recombinant vesicular stomatitis virus-vectored Zaire Ebola (rVSVΔG-ZEBOV-GP) vaccine …

[PDF][PDF] Global blood miRNA profiling unravels early signatures of immunogenicity of Ebola vaccine rVSVΔG-ZEBOV-GP

E Vianello, J Persson, B Andersson, S van Veen… - iScience, 2023 - cell.com
The vectored Ebola vaccine rVSVΔG-ZEBOV-GP elicits protection against Ebola Virus
Disease (EVD). In a study of forty-eight healthy adult volunteers who received either the …

A Recombinant Vesicular Stomatitis Virus–Based Vaccine Provides Postexposure Protection Against Bundibugyo Ebolavirus Infection

C Woolsey, J Strampe, KA Fenton… - The Journal of …, 2023 - academic.oup.com
Abstract Background The filovirus Bundibugyo virus (BDBV) causes severe disease with a
mortality rate of approximately 20%–51%. The only licensed filovirus vaccine in the United …